What if there was a simple, inexpensive blood test to detect cancer early?

Learn More

ITUS Corporation funds, develops, acquires and licenses emerging technologies in areas such as biotechnology. The Company’s primary focus is Cchek™, a platform for non-invasive blood tests for the early detection of solid tumor based cancers.

ITUS in the News

In this Fox News segment, Dr. Manny Alvaraez discusses Cancer4Pres.org and Cchek™ with Rob Berman, CEO & President of ITUS Corporation.

Itus In The News

ITUS Corporation is developing a platform for inexpensive, non-invasive cancer screening blood tests for the early detection of tumor based cancers.

Learn More
NASDAQ ITUS
Price
Change
Volume
Day Range
52 Wk Range

Sign Up for Email Updates

Be the first to receive the breaking news

Sign Up